Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, CAR-T cell therapy research, and Cancer Treatment and Pharmacology.
Implantation of engineered adipocytes suppresses tumor progression in cancer models
Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ
Autophagy-targeted NBR1–p62/SQSTM1 complexes promote breast cancer metastasis by sequestering ITCH
AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization
A human breast atlas integrating single-cell proteomics and transcriptomics
Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i> : Insights from a Large Neoadjuvant Endocrine Therapy Cohort
Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids
Organoid cultures from normal and cancer-prone human breast tissues preserve complex epithelial lineages
A large peptidome dataset improves HLA class I epitope prediction across most of the human population
A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67